The document discusses the use of animal models and siRNA technologies to study and potentially treat autosomal dominantly inherited neurodegenerative diseases. It notes that siRNA can cause gene silencing and has potential for treating these diseases, but developing safe and effective human therapies requires testing treatments in mouse models first. The document also provides background on siRNA and examples of neurodegenerative diseases that could benefit from new gene therapies.